Slack has confidentially filed for a direct listing that will allow SoftBank Vision Fund, Comcast Ventures and Alphabet unit GV to sell shares.

6 Dimensions Capital is set to exit immuno-oncology drug developer TCR² Therapeutics in an offering likely to raise between $70m and $80m.

VetMedUni biopharmaceutical spinout Marinomed Biotech has completed its IPO to attain a market cap of $109m.

A leading company in the e-signature and digital transaction management space, San Francisco-based DocuSign went public in April last year, with a market capitalization of $4.4bn.

Rob Lavine, News editor for Global Corporate Venturing, reviews the trends in venturing from 2018

Maoyan is floating in Hong Kong at the bottom of its range, in an offering that will provide exits to Enlight, Tencent and Meituan Dianping.

Eli Lilly-backed ophthalmic technology developer Avedro has filed for an $86.3m initial public offering having previously raised $220m in debt and equity financing.

Rob Lavine, News editor for Global Corporate Venturing, reviews the trends in venturing from 2018

The Novel-backed second-hand luxury goods marketplace, valued at $745m in its last round, has approached investment banks about underwriting an initial public offering this year.

The Meituan Dianping spinoff, which is also backed by Enlight Media and Tencent, has set the range for its Hong Kong initial public offering.